Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Free access | 10.1172/JCI106768

Pathogenesis of hypocalcemia in magnesium depletion: Normal end-organ responsiveness to parathyroid hormone

Se Mo Suh, Adele Csima, and Donald Fraser

Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada

Department of Physiology, University of Toronto, Toronto, Ontario, Canada

Department of Epidemiology and Biometrics, University of Toronto, Toronto, Ontario, Canada

Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada

Find articles by Suh, S. in: PubMed | Google Scholar

Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada

Department of Physiology, University of Toronto, Toronto, Ontario, Canada

Department of Epidemiology and Biometrics, University of Toronto, Toronto, Ontario, Canada

Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada

Find articles by Csima, A. in: PubMed | Google Scholar

Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada

Department of Physiology, University of Toronto, Toronto, Ontario, Canada

Department of Epidemiology and Biometrics, University of Toronto, Toronto, Ontario, Canada

Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada

Find articles by Fraser, D. in: PubMed | Google Scholar

Published December 1, 1971 - More info

Published in Volume 50, Issue 12 on December 1, 1971
J Clin Invest. 1971;50(12):2668–2678. https://doi.org/10.1172/JCI106768.
© 1971 The American Society for Clinical Investigation
Published December 1, 1971 - Version history
View PDF
Abstract

Hypocalcemia in the hypomagnesemic state in man is usually attributed to refractoriness of end-organs to the calcemic action of parathyroid hormone. We studied the responsiveness of end-organs to bovine parathyroid extract (PTE) in magnesium-depleted and control dogs by the following three methods after thyroparathyroidectomy: (a) assessment of the calcemic response to a set dose of PTE (0.3 U/kg per hr); (b) assessment of PTE dose required to attain normocalcemia; (c) evaluation of regression lines of plasma calcium concentration on PTE dose. The calcemic response of magnesium-depleted thyroparathyroidectomized puppies to a set dose of PTE was similar to that of control puppies. There was no significant difference in the dose of PTE required to attain normocalcemia nor in the dose-response relations between the plasma calcium concentration and the PTE dose. In a group of magnesium-depleted puppies with intact thyroid and parathyroid glands, the dose of PTE required to attain normocalcemia was similar to that required in thyroparathyroidectomized animals, indicating calcitonin was not a factor contributing to hypocalcemia. We conclude that hypocalcemia in magnesium-depleted puppies is not due to refractoriness of end-organs to the calcium-mobilizing action of parathyroid hormone. Defective synthesis or diminished secretion of parathyroid hormone is suggested as an explanation.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2668
page 2668
icon of scanned page 2669
page 2669
icon of scanned page 2670
page 2670
icon of scanned page 2671
page 2671
icon of scanned page 2672
page 2672
icon of scanned page 2673
page 2673
icon of scanned page 2674
page 2674
icon of scanned page 2675
page 2675
icon of scanned page 2676
page 2676
icon of scanned page 2677
page 2677
icon of scanned page 2678
page 2678
Version history
  • Version 1 (December 1, 1971): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts